Cited by 140Estrogen and related hormone effectsAdrenal Hormones and DisordersStress Responses and Cortisol

Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms

Open access
Flammer, Jamie R., Rogatsky, Inez·2011·Molecular Endocrinology

Abstract

For decades, natural and synthetic glucocorticoids (GC) have been among the most commonly prescribed classes of immunomodulatory drugs. Their unsurpassed immunosuppressive and antiinflammatory activity along with cost-effectiveness makes these compounds a treatment of choice for the majority of autoimmune and inflammatory diseases, despite serious side effects that frequently accompany GC therapy. The activated GC receptor (GR) that conveys the signaling information of these steroid ligands to the transcriptional machinery engages a number of pathways to ultimately suppress autoimmune responses. Of those, GR-mediated apoptosis of numerous cell types of hematopoietic origin and suppression of proinflammatory cytokine gene expression have been described as the primary mechanisms responsible for the antiinflammatory actions of GC. However, along with the ever-increasing appreciation of the complex functions of the immune system in health and disease, we are beginning to recognize new facets of GR actions in immune cells. Here, we give a brief overview of the extensive literature on the antiinflammatory activities of GC and discuss in greater detail the unexpected pathways, factors, and mechanisms that have recently begun to emerge as novel targets for GC-mediated immunosuppression.

Integrity signals

Registry

Crossref · 10.1210/me.2011-0068

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liganded GRs impact gene transcription through non-genomic mechanisms that do not require de novo protein synthesis and underlie the more rapid actions of GCs.

    “In addition to their genomic actions, liganded GRs also impact on gene transcription through various non-genomic mechanisms. These mechanisms do not require de novo protein synthesis and thus underlie the more rapid actions of GCs.”
  • Prominent non-genomic examples include mRNA destabilization, competition for co-activators, and interference with the binding of transcription factors to DNA.

    “Prominent examples include mRNA destabilization, competition for co-activators [e.g., CREB-binding protein (CBP), p300, and GRIP], and interference with the binding of transcription factors to DNA (91–94).”

Cites

Flagged first, then by citations

1 of the 131 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Flammer, J. R., & Rogatsky, I.
Affiliations
Hospital for Special Surgery (US)
Venue
Molecular Endocrinology
Published
2011-07-01
Volume
25
Issue
7
Pages
1075-1086
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2021846928
Cited by
140
References
131
Citations by year
2026: 5 · 2025: 8 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 3 · 2019: 9 · 2018: 11 · 2017: 8 · 2016: 6 · 2015: 10 · 2014: 22 · 2013: 10 · 2012: 15
FWCI
1.68
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
glucocorticoids, glucocorticoid receptor, autoimmunity, immunosuppression, anti-inflammatory mechanism, apoptosis, inflammatory cytokines, hematopoietic cells, novel therapeutic targets, glucocorticoid adverse effects
MeSH terms
Animals, Glucocorticoids, T-Lymphocytes, Helper-Inducer, Humans, Interferon Type I, Lymphocyte Activation, Receptors, Glucocorticoid, Signal Transduction, Autoimmunity, STAT Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review